Jenkem Technology Co Ltd banner

Jenkem Technology Co Ltd
SSE:688356

Watchlist Manager
Jenkem Technology Co Ltd Logo
Jenkem Technology Co Ltd
SSE:688356
Watchlist
Price: 97.36 CNY 2.97% Market Closed
Market Cap: ¥5.9B

Net Margin

10.5%
Current
Declining
by 17.4%
vs 3-y average of 27.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
10.5%
=
Net Income
¥23.9m
/
Revenue
¥228.2m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
10.5%
=
Net Income
¥23.9m
/
Revenue
¥228.2m

Peer Comparison

Country Company Market Cap Net
Margin
CN
Jenkem Technology Co Ltd
SSE:688356
5.9B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
997.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.6B USD
Loading...
CH
Roche Holding AG
SIX:ROG
281.8B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
303.5B USD
Loading...
CH
Novartis AG
SIX:NOVN
231.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
218.1B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
154.7B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD
Loading...

Market Distribution

Higher than 74% of companies in China
Percentile
74rd
Based on 8 721 companies
74rd percentile
10.5%
Low
-416 945.9% — -1.5%
Typical Range
-1.5% — 8.9%
High
8.9% — 17 382.1%
Distribution Statistics
China
Min -416 945.9%
30th Percentile -1.5%
Median 3.5%
70th Percentile 8.9%
Max 17 382.1%

Jenkem Technology Co Ltd
Glance View

Market Cap
5.9B CNY
Industry
Pharmaceuticals

Jenkem Technology Co., Ltd. engages in the research, development, production and sales of medical polyethylene glycol (PEG) and its active derivatives. The company is headquartered in Beijing, Beijing and currently employs 208 full-time employees. The company went IPO on 2020-08-26. The firm's primary products are medical polyethylene glycol and its active derivatives, which are used in research, development and production of drugs and medial devices, scientific research institutions and other fields. The firm is also involved in providing technical services, including patent and non-patent technology licensing services, as well as research and development services.

Intrinsic Value
72.07 CNY
Overvaluation 26%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
10.5%
=
Net Income
¥23.9m
/
Revenue
¥228.2m
What is Jenkem Technology Co Ltd's current Net Margin?

The current Net Margin for Jenkem Technology Co Ltd is 10.5%, which is below its 3-year median of 27.9%.

How has Net Margin changed over time?

Over the last 3 years, Jenkem Technology Co Ltd’s Net Margin has decreased from 50.3% to 10.5%. During this period, it reached a low of 10.5% on Jul 30, 2025 and a high of 50.3% on May 30, 2022.

Back to Top